title: Posterior reversible encephalopathy syndrome in a patient with ANCA-associated vasculitis.
abstract: Posterior reversible encephalopathy syndrome (PRES) is a clinical syndrome that manifests with the onset of headache, confusion or decreased level of consciousness, visual changes, and seizures in conjunction with the typical neuroimaging features of posterior cerebral white matter changes, which are usually reversible. This syndrome has been associated with hypertension, eclampsia, renal insufficiency, immunosuppressive drugs, and connective-tissue diseases. To our knowledge, only four cases of PRES associated with antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis have been reported in the literature. Here, we present a patient with ANCA-associated vasculitis complicated by PRES.
authors.affiliation: Section of Immunology, Allergy and Rheumatology, Baylor College of Medicine, Houston, TX, USA. alex17go@yahoo.com
authors.forename: Alexandra Gonzalez
authors.initials: AG
authors.lastname: Fuentes
authors.forename: Ashwini
authors.initials: A
authors.lastname: Komarla
authors.forename: John I
authors.initials: JI
authors.lastname: Gomez
mesh_terms: D000368:Aged; D056648:Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis / Q000150:complications* / Q000175:diagnosis / Q000628:therapy; D000927:Anticonvulsants / Q000627:therapeutic use; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001706:Biopsy; D001921:Brain / Q000473:pathology; D005260:Female; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D007668:Kidney / Q000473:pathology; D008279:Magnetic Resonance Imaging; D054038:Posterior Leukoencephalopathy Syndrome / Q000175:diagnosis / Q000209:etiology* / Q000628:therapy; D006435:Renal Dialysis; D016896:Treatment Outcome
chemical_list: D000927:Anticonvulsants; D000959:Antihypertensive Agents; D007166:Immunosuppressive Agents